Advent International Invests 3150 Crore in Yatharth Hospital

Yatharth Hospital and Trauma Care Services shares climbed 9.67% to a 52-week high of ₹1,077.90 on the BSE following the announcement of a major capital injection. Global private equity firm Advent International has agreed to acquire a 24.9% minority stake in the Noida-based healthcare provider for ₹3,150 crore. The transaction, which involves primary capital, is subject to customary closing conditions but has already driven the company's market capitalization to ₹10,348 crore, with over one lakh shares changing hands.

The investment is designed to accelerate the company's expansion across North India and strengthen its multi-speciality network. Founded in 2008, Yatharth currently operates nine hospitals with approximately 2,800 operational beds and an announced capacity of 3,250. The Tyagi family, who founded the chain, will retain their position as the largest shareholders and continue to guide the long-term strategy, while Advent brings global healthcare expertise and operational insights to the partnership.

Capital supports North India expansion

Yatharth Hospitals stated that the infusion will help validate its platform and support the next phase of growth. The company has previously expanded through both organic development and inorganic acquisitions. Advent International, which oversees more than $109 billion in assets across 45 countries, views the deal as a commitment to India's structural healthcare growth. The firm cited expanding access and quality improvements as key drivers for the sector's consolidation.

Advent’s managing director noted that the partnership combines global experience with the company's differentiated clinical capabilities. The transaction is expected to enhance Yatharth’s ability to extend its footprint and improve operational execution. According to reports from GN stocks/shares-surge, the market reaction reflects confidence in the hospital chain's capacity to leverage new capital for infrastructure and service expansion in the region.

Market reaction to the deal

The stock price movement on Thursday marked a fresh 52-week high, indicating strong investor sentiment toward the healthcare sector. The deal structure allows Advent to hold a significant minority interest without taking control, preserving the founder-led management model. This approach is common in private equity investments where operational continuity is valued alongside capital provision. The immediate impact on valuation underscores the market's appreciation for the company's existing bed capacity and network density.